The Rheumatologist
COVID-19 News
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Systemic Lupus Erythematosus Resource Center
      • Rheumatoid Arthritis Resource Center
      • Gout Resource Center
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Partners in Advancing Rheumatology

Partners in Advancing Rheumatology

August 8, 2012 • By James O’Dell, MD, and David I. Daikh, MD, PhD

  • Tweet
  • Email
Print-Friendly Version / Save PDF
Dr. O'Dell
Dr. O’Dell

You Might Also Like
  • ACR Research and Education Foundation Meets with NIAMS and AF to Discuss Funding
  • American College of Rheumatology Award Provides Researchers Time for Career Development
  • Health Professional Careers in Rheumatology Research
Explore This Issue
August 2012
Dr. O'Dell
Dr. Daikh

One of the major goals of the ACR is to promote basic, translational, clinical, and health-services research aimed at improving the health of patients with rheumatic diseases. The ACR supports research and education through its annual meetings and clinical symposia, publication of its journals—Arthritis & Rheumatism and Arthritis Care & Research—advocacy to increase funding of rheumatology research, and a strong collaboration with our own Research and Education Foundation (REF).

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

The REF supports the overall research goals of the ACR on several fronts. It provides a robust portfolio of awards and grants to address critical shortfalls in the overall rheumatology landscape. The REF also promotes mentorship activities through efforts such as the REF Investigators’ Meeting, held in conjunction with the ACR Rheumatology Research Workshop, which brings junior and senior investigators together for mentorship opportunities. In conjunction with the National Institutes of Health, the REF leads discussions about how to best develop the careers of physician–scientists involved in rheumatic disease research.

Great Strides in Research Support

The ACR supports the goals of the Foundation as well. During Dr. O’Dell’s time as the REF president in 2006–2008, the ACR was generous in its support by becoming the first $5-million donor to the Within Our Reach: Finding a Cure for Rheumatoid Arthritis campaign. Five years later, in November 2011, the REF launched the Journey to Cure campaign to raise $60 million—double the goal of the first campaign—and the ACR again was the first to step up, donating $5 million. This campaign will fund both the core award programs and the disease-targeted research grants.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

As we look forward to a new fundraising campaign, there is the strong sense in the organization that, at the same time we embark on the next prodigious goal, we are now also engaged in “business as usual,” because raising major funds to support training and research is what the REF does—and we do it very well.

We are excited to announce that the REF is poised to lead a new era of rheumatology support that focuses on advancing treatment and finding medical breakthroughs to cure rheumatic diseases. This year, the REF will fund nearly $12 million in fellowship training grants, career development awards, and disease-targeted research grants representing an incredible investment in innovative research and developing successful careers in rheumatology—both research and practice.

In September, the REF will—for the first time—fund $2 million in investigator-initiated clinical trials. This is a major step forward in our quest to advance treatment and find cures. Outcomes from these grants will lead to new insights into the treatment of rheumatoid arthritis (RA), answering questions about investigational drugs or looking at new ways of using known treatments relevant to RA. In addition to these clinical trials, the REF continues to fund $1.2 million in translational RA research as part of the highly successful Within Our Reach campaign.

ad goes here:advert-3
ADVERTISEMENT
SCROLL TO CONTINUE

Pages: 1 2 3 | Single Page

Filed Under: Career Development, Education & Training, Legislation & Advocacy, President's Perspective, Professional Topics, Rheumatoid Arthritis, Spondyloarthritis Tagged With: AC&R, Advocacy, American College of Rheumatology, Juvenile idiopathic arthritis, Research, Rheumatology Research FoundationIssue: August 2012

You Might Also Like:
  • ACR Research and Education Foundation Meets with NIAMS and AF to Discuss Funding
  • American College of Rheumatology Award Provides Researchers Time for Career Development
  • Health Professional Careers in Rheumatology Research
  • Rheumatology Research Foundation Updates Awards and Grants Program

American College of Rheumatology

Visit the official website for the American College of Rheumatology.

Visit the ACR »

Simple Tasks

Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.

Visit the Simple Tasks site »

ACR Convergence

Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.

Visit the ACR Convergence site »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2022 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)